| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 61.745 | 96.466 | 42.560 | 54.407 | 43.188 | 41.970 | 56.817 | 57.899 | 57.622 | 31.983 |
| Total Income - EUR | 62.502 | 97.294 | 43.320 | 54.587 | 43.512 | 42.052 | 57.290 | 58.505 | 61.501 | 34.626 |
| Total Expenses - EUR | 23.823 | 32.894 | 19.132 | 37.052 | 35.802 | 35.820 | 43.646 | 40.515 | 49.671 | 34.292 |
| Gross Profit/Loss - EUR | 38.679 | 64.400 | 24.188 | 17.535 | 7.710 | 6.232 | 13.644 | 17.990 | 11.831 | 334 |
| Net Profit/Loss - EUR | 36.801 | 61.481 | 22.888 | 16.989 | 7.275 | 5.827 | 13.086 | 17.410 | 11.259 | 56 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cromed Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 42.228 | 43.085 | 41.772 | 59.745 | 50.158 | 43.101 | 33.259 | 24.855 | 16.759 | 11.432 |
| Current Assets | 29.400 | 42.961 | 32.587 | 26.395 | 23.860 | 35.795 | 51.367 | 59.370 | 28.816 | 32.554 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 9.548 | 8.148 | 11.519 | 9.673 | 7.499 | 8.458 | 9.221 | 21.883 | 10.989 | 11.773 |
| Cash | 19.852 | 34.814 | 21.067 | 16.721 | 16.361 | 27.337 | 42.146 | 37.487 | 17.827 | 20.781 |
| Shareholders Funds | 68.863 | 61.690 | 73.654 | 84.779 | 73.553 | 77.986 | 83.886 | 82.901 | 44.290 | 41.109 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.764 | 25.096 | 705 | 1.361 | 465 | 910 | 741 | 1.324 | 1.285 | 2.877 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Cromed Research Srl